Showing results (101-110 of 211) with videos related to

Sort By:
Pageof 22
The Lancet. Haematology|September 12, 2024
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trialClaire N Harrison, Ruben Mesa, Moshe Talpaz, et al.
Hematological Oncology|August 8, 2025
Treatment-Free Remission in Chronic Phase Chronic Myeloid Leukemia After Nilotinib De-Escalation: 96-Week Update of the DANTE StudyAlessandra Iurlo, Massimo Breccia, Fabio Stagno, et al.
Blood Research|August 15, 2020
Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): the GIMS (Glivec to Imatinib Switch) studyMaria Gemelli, Elena Maria Elli, Chiara Elena, et al.
Hematological Oncology|July 21, 2012
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemiaRoberto Latagliata, Massimo Breccia, Carmen Fava, et al.
Frontiers in Pharmacology|June 12, 2023
Prospective monitoring of chronic myeloid leukemia patients from the time of TKI discontinuation: the fate of peripheral blood CD26<sup>+</sup> leukemia stem cellsPaola Pacelli, Adele Santoni, Anna Sicuranza, et al.
Acta Haematologica|September 18, 2024
Bosutinib Treatment of Chronic Myeloid Leukemia in LombardyAlessandra Iurlo, Cristina Bucelli, Tamara Intermesoli, et al.
Hematological Oncology|September 26, 2020
Cytogenetic study in primary myelofibrosis at diagnosis: Clinical and histological association and impact on survival according to WHO 2017 classification in an Italian multicenter seriesAlessandra Iurlo, Francesca Palandri, Elena Maria Elli, et al.
British Journal of Haematology|August 19, 2014
A lower intensity of treatment may underlie the increased risk of thrombosis in young patients with masked polycythaemia veraFederico Lussana, Alessandra Carobbio, Maria L Randi, et al.
Annals of Hematology|April 21, 2018
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practiceMassimo Breccia, Elisabetta Abruzzese, Fausto Castagnetti, et al.
Annals of Hematology|April 20, 2023
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trialsLuigia Luciano, Roberto Latagliata, Gabriele Gugliotta, et al.
Pageof 22